Today: 16 April 2026
Malaysia tells lawmakers Lynas rare earth licence rules won’t soften under US minerals pact
6 March 2026
1 min read

Malaysia tells lawmakers Lynas rare earth licence rules won’t soften under US minerals pact

Kuala Lumpur, March 6, 2026, 14:39 MYT

  • Malaysia’s trade ministry made it clear US promises on licensing certainty don’t trump the technical requirements imposed on Lynas.
  • Lynas announced its Malaysian operating licence has been renewed for 10 years, effective March 3.
  • An environmental group is calling on Malaysia to return radioactive waste to Australia.

Malaysia’s trade ministry said the new 10-year licence granted to Lynas Rare Earths won’t alter any of the technical conditions already imposed on its local operations, despite commitments under a reciprocal trade statement and a critical minerals memorandum signed with the United States.

It’s a pressing concern in Kuala Lumpur: the government is seeking foreign investment and partners in critical minerals, yet public outrage continues over radioactive by-products at Lynas’ Malaysian processing site.

The Ministry of Investment, Trade and Industry (MITI) told the upper house in a written response that its critical minerals MoU with the United States includes working together on “good regulatory practices,” like making it easier to obtain permits and licences. Still, the ministry stressed the government retains full authority to enforce technical requirements.

MITI said discussions are still in the early phase between Khazanah Nasional, the state investor, and Chinese firms over developing Malaysia’s rare earth sector. No final deals have been reached.

The ministry said there’s still no deal in place for transferring heavy rare earth element separation technology—details like scope and timing remain unsettled. That highlights just how tough it is for countries trying to set up supply chains that don’t rely on China.

MITI noted that, right now, commercial-scale HREE production happens solely at processing plants in China and at Lynas’s facility in Kuantan.

Australia-listed Lynas said this week it got confirmation from Malaysia’s Department of Atomic Energy that its Lynas Malaysia operating licence has been renewed for 10 years starting March 3, with the official licence to follow “in due course”. CEO Amanda Lacaze pointed to the decade-long renewal as providing “greater investment certainty” to customers and supply chain partners.

Malaysia’s science minister says the new policy bars any new permanent disposal site for radioactive waste, requiring Water Leach Purification (WLP) residue — the by-product from processing — to stop by 2031. All existing WLP must be dealt with using approved approaches.

Still, political tensions remain. Sahabat Alam Malaysia, an environmental NGO, labeled the licence renewal a “smokescreen,” arguing that shipping radioactive waste back to Australia remains “the best and most effective option.” The group warned that Malaysia risks a long-term burden if the promised treatment technology fails to deliver at scale. foe-malaysia.org

Stock Market Today

  • Amerigo Resources Q1 2026 Results Signal Capital Allocation Shift with Dividend and Buyback
    April 15, 2026, 9:21 PM EDT. Amerigo Resources Ltd. (TSX:ARG) reported Q1 2026 operating results reaffirming full-year copper and molybdenum production guidance. The company completed a C$5.9 million share buyback and declared a C$0.16 per-share performance dividend payable in May 2026. Despite scheduled maintenance, cash costs trended below guidance, highlighting operational efficiency. Amerigo's single-asset strategy focuses on cash generation and capital returns, underscored by this combination of buyback and special dividend. Shares have risen but appear undervalued by roughly 30% against fair value estimates ranging from C$5.26 to C$9.15. However, recent insider selling adds risk. The firm's capital discipline and market positioning suggest investors watch copper prices, MVC execution, and future capital decisions closely.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Westpac Banking Corporation Plans to End SEC Reporting While Keeping U.S. Bond Sales
Previous Story

Westpac Banking Corporation Plans to End SEC Reporting While Keeping U.S. Bond Sales

Evolution Mining Limited shares sink 6% as ASX gold miners sell off despite bullion rebound
Next Story

Evolution Mining Limited shares sink 6% as ASX gold miners sell off despite bullion rebound

Go toTop